Overview
The recent Lancet Oncology study led by Kayleigh Bhangdia of the Institute for Health Metrics and Evaluation (IHME) projects a sharp rise in breast cancer burden worldwide, with India witnessing a **477% increase in cases** and **352% rise in deaths** from 1990 to 2023.
Key Developments
- Global cases expected to reach **3.5 million by 2050**, a one‑third rise from 2023.
- Annual deaths could climb to **1.37 million**, a **44% increase**.
- India recorded **2.03 lakh cases** in 2023, up **477%** since 1990, with **over 1 lakh deaths** (352% rise).
- Low‑ and middle‑income countries (LMICs) show a **147.2% surge** in age‑standardised incidence rate (ASIR), while high‑income nations see only **1.2%** growth.
- High‑income nations experienced a **‑29.9% decline** in age‑standardised mortality rate (ASMR), contrasted with a **99.3% rise** in LMICs.
Important Facts
The disparity stems from differences in screening programmes, early diagnosis, and treatment infrastructure. High‑income countries benefit from organized mammography, advanced therapeutics, and robust health financing, leading to stable incidence and falling mortality. In contrast, LMICs face delayed diagnosis, limited access to quality care, and higher fatality rates, threatening gains in women’s health.
Preventive measures—**non‑smoking, regular physical activity, reduced red‑meat intake, and maintaining healthy weight**—could avert over **25% of healthy years lost** to breast cancer, underscoring the role of lifestyle in disease control.
Exam Relevance
Understanding this health trend is vital for multiple GS papers:
- GS4 (Health & Family Welfare): Analyses of disease burden, health‑system gaps, and preventive strategies.
- GS3 (Economy): Impact of cancer on productivity, health‑care expenditure, and insurance frameworks.
- GS2 (Polity): Role of government schemes (e.g., National Cancer Control Programme) and regulatory bodies in scaling screening.
Way Forward
Policy recommendations for India and similar LMICs include:
- Establish **nationwide, affordable screening** (clinical breast examination, low‑cost imaging) targeting women aged 30‑49.
- Strengthen **primary health‑care linkages** for timely referral and treatment.
- Increase **public‑private partnerships** to expand oncology infrastructure and subsidise chemotherapy/radiotherapy.
- Integrate **health‑promotion campaigns** on lifestyle risk factors within existing Swasthya Sankalp initiatives.
- Utilise **IHME data** for evidence‑based resource allocation and monitoring of progress toward Sustainable Development Goal 3.4 (reduce premature mortality from non‑communicable diseases).
Addressing the rising breast cancer burden will require coordinated action across health, finance, and social sectors, aligning with India’s broader agenda of universal health coverage and gender equity.